Adam D. Hughes

11 Patents

• US123515612025

  Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid and Uses Thereof

  Theravance Biopharma R&D IP, LLC

  0 cites
• US120168352024

  Neprilysin Inhibitors

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites
• US119198882024

  Neprilysin Inhibitors

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites
• US118514432023

  Neprilysin Inhibitors

  Theravance Biopharma R&D IP, LLC

  0 cites
• US117307202023

  ALK5 Inhibitors

  Theravance Biopharma R&D IP, LLC

  0 cites
• US117185912023

  Crystalline (2s,4r)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- Methylpentanoic Acid and Uses Thereof

  Theravance Biopharma R&D IP, LLC

  0 cites
• US116738792023

  Substituted Pyrimidines and Methods of Use

  Theravance Biopharma R&D IP, LLC

  0 cites
• US116423322023

  (2r,4r)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic Acid

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites
• US116344132023

  Neprilysin Inhibitors

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites
• US115901162023

  Substituted Pyridines and Methods of Use

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites
• US115476872023

  Neprilysin Inhibitors

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites